To evaluate the NID2 promoter hypermethylation in NPC and ESCC, we identified the region that showed distinct differential methylation in selected NPC cell lines, when compared to the NP cell lines (Supplementary Figure S2). This evidence concerns the gene NID2 and nasopharyngeal carcinoma.